相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
4°C, sealed storage, away from moisture
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
600734-06-3
- 规格:
10 mM * 1 mL/2 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1097.0 |
|---|---|---|---|
| 规格: | 2 mg | 产品价格: | ¥666.0 |
| 规格: | 5 mg | 产品价格: | ¥997.0 |
| 规格: | 10 mg | 产品价格: | ¥1895.0 |
| 规格: | 25 mg | 产品价格: | ¥4169.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Bay 65-1942 hydrochloride
CAS No. : 600734-06-3
MCE 国际站:Bay 65-1942 hydrochloride
产品活性:Bay 65-1942 hydrochloride 是一种 ATP 竞争性的选择性 IKKβ 抑制剂。
研究领域:NF-κB
作用靶点:IKK
In Vitro: Delivery of Bay 65-1942 prior to ischemia significantly decreases left ventricular infarct size compared with animals receiving vehicle. Compared with sham animals, animals receiving vehicle have a significant increase in the infarct-to-area at risk (AAR) ratio (70.7±3.4 vs. 5.8±3.4%, P<0.05). This ratio is significantly reduced by treatment with Bay 65-1942 at each time point (prior to ischemia 42.7±4.1%, at reperfusion 42.7±7.5%, 2 h of reperfusion 29.4±5.2%; each group P<0.05 vs. vehicle). Animals pretreated with Bay 65-1942 (n=3) have significantly attenuated CK-MB levels compared with those animals without treatment prior to IR (14,170 ±3,219 units, P<0.05 vs. vehicle).
In Vivo: Inhibitors of MEK (AZD6244) and IKK (BAY 65-1942) are used at their IC50 concentrations, as determined by a 48 hour MTS assay, which achieve sufficient inhibition of kinase activity. MYL-R cells are treated for 24 hours with AZD6244 (5 µM), BAY 65-1942 (10 µM), or a combination of these inhibitors at the same concentrations. AZD6244 and BAY 65-1942 demonstrate synergistic inhibition of cell viability at the dose combination (5 µM AZD6244+10 µM BAY 65-1942), which correlates with IC75 (CI = 0.48±0.01). Synergism is also indicated at the IC50 (CI = 0.56±0.09) and IC90 (CI = 0.46±0.02) dose combinations reported by the software (CI values are the mean of three independent experiments, ± standard deviation). AZD6244 and BAY 65-1942 treatment induces 2- and 1.3-fold caspase 3/7 activation, respectively, compared to the DMSO-treated cells. Treatment with a combination of AZD6244 plus BAY 65-1942 leads to a 3.2-fold increase in caspase 3/7 activity.
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | NF-κB Signaling Compound Library | Stem Cell Signaling Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Anti-Liver Cancer Compound Library | Anti-Prostate Cancer Compound Library | Highly Selective Inhibitors Library | Serine/Threonine Kinase Inhibitor Library | BAY 11-7082 | Resveratrol | BX795 | GSK8612 | TPCA-1 | Amlexanox | MRT67307 | IMD-0354 | IKK 16 | BMS-345541 | MLN120B | ACHP Hydrochloride | BAY-985 | HOIPIN-1 | PS-1145 | TBK1/IKKε-IN-5 | Vinpocetine | BI605906 | Tizoxanide | SC-514 | GS143 | INH14 | BAY32-5915 | NF-κB-IN-1 | LY2409881 trihydrochloride | Malachite green hemioxalate | Plantainoside D | TBK1/IKKε-IN-2
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验5.99 5.82 5.69 5.60 5.52 5.46 5.37 5.27 5.17 5.06 4.96 4.85 6 7 6.54 5.89 5.52 5.28 5.12 4.99 4.90 4.82 4.76 4.67 4.57 4.47 4.36 4.25 4.14 7 8 6.06 5.42 5.05 4.82 4.65 4.53 4.43 4.36 4.29 4.20 4.10 4.00 3.89 3.78 3.67 8 9 5.71 5.08 4.72 4.48
09 45 59 34 68 49 12 72 07 34 45 99 27 72 95 14 20 31 16 93 32 43 50 27 89 87 19 20 15 37 00 49 52 85 66 60 44 38 68 88 11 80 21 68 34 30 13 70 55 74 30 77 40 44 22 78 84 26 04 33 46 09 52 68 07 97 06 57 22 74 57 25 65 76 59 29 97 68 60 71 91 38 67
人用过?效果如何?因为我要做裸鼠成瘤实验,不知道这种多肽的片段是否可以做体内实验?如果可以,一般采用瘤周注射还是.....?或是还有更好的办法??很着急,希望有经验的同道给予指点,万分感谢。 shiying0517 Bay11-7082 lwjssry 楼主为什么不做IKK dominant negtive的稳定筛选? 我用的是BAY 11-7082,是IKK抑制剂,效果不错,sigma的,可以试试 Merck 公司
技术资料暂无技术资料 索取技术资料

















